Are demyelinating lesions in multiple sclerosis (MS) referred to as plaques?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Demyelinating Lesions in Multiple Sclerosis: Plaques

Yes, demyelinating lesions in multiple sclerosis are indeed called plaques. 1

Characteristics of MS Plaques

  • MS plaques are focal areas of demyelination in the central nervous system, representing the hallmark pathological feature of the disease 1, 2
  • These lesions are typically visible on MRI as hyperintense areas on T2-weighted scans and can be found in both white and gray matter 1
  • MS plaques form around the microvasculature, with many showing a characteristic central vein (central vein sign) that helps distinguish them from other white matter abnormalities 1
  • Some chronic MS plaques develop a distinctive hypointense rim on susceptibility-based MRI, which may persist for years and reflects iron-laden microglia and/or macrophages at the lesion edge 1

Types of MS Plaques

  • White matter plaques are the most commonly recognized and are typically found in periventricular, juxtacortical, infratentorial, and spinal cord regions 1, 3
  • Cortical plaques involve the gray matter and have been classified into different types:
    • Type I (leukocortical): affecting both gray matter and white matter 1
    • Type II: small perivenous intracortical lesions not affecting white matter 1
    • Type III: subpial demyelination extending inward from the brain surface (most frequent type) 1
    • Type IV: lesions extending through the entire cortical width 1
  • Cortical plaques are more difficult to detect on conventional MRI but are better visualized with specialized sequences such as double inversion recovery (DIR), phase-sensitive inversion recovery (PSIR), or T1-weighted MPRAGE 1

Pathological Heterogeneity of MS Plaques

  • Four distinct patterns of demyelination have been identified in MS plaques, suggesting heterogeneity in pathogenesis 4
  • Patterns I and II resemble T-cell-mediated or T-cell plus antibody-mediated autoimmune processes 4
  • Patterns III and IV suggest primary oligodendrocyte dystrophy, similar to virus or toxin-induced demyelination 4
  • Despite this heterogeneity between patients, multiple active lesions within the same patient typically show the same pattern 4

Advanced Imaging of MS Plaques

  • High-field MRI (3.0 Tesla) allows detection of significantly more lesions compared to lower field strengths, with improved recognition of cortical, infratentorial, and periventricular lesions 1, 5
  • Ultra-high-field MRI (7.0 Tesla) provides better definition of MS plaques with respect to their morphology and association with the vasculature 1, 5
  • The presence of a central small vein and rim of hypointensity on T2*-weighted imaging at high field strengths is a distinctive feature of MS plaques that helps differentiate them from other conditions 1, 5

Clinical Significance

  • MS plaques represent a common pathological endpoint of various immunological mechanisms of myelin destruction 6, 7
  • Beyond the visible focal plaques, MS also causes diffuse injury to normal-appearing white matter and gray matter, contributing to the overall disease burden 7, 2
  • Cortical plaques are particularly relevant for cognitive dysfunction in MS patients and are more prevalent in progressive forms of the disease 8
  • The distribution and characteristics of plaques help distinguish MS from other inflammatory demyelinating diseases 1, 3

Diagnostic Implications

  • MRI visualization of characteristic plaques is essential for MS diagnosis, demonstrating dissemination in space and time 1, 3
  • The term "plaque" is the standard pathological terminology for these lesions, reflecting their appearance as well-demarcated areas of demyelination 6, 2
  • Specific features of plaques, such as their perivenular location, shape, and distribution pattern, help differentiate MS from mimics 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2003

Guideline

Diagnostic Criteria and Clinical Presentation of Multiple Sclerosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diseases Requiring High Tesla MRI Where Inspire Device Would Be Problematic

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The immunopathology of multiple sclerosis: an overview.

Brain pathology (Zurich, Switzerland), 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.